Life in Remission and Dating After Cancer | GOOD SUPPORT (Episode 3)

Host Angela Trimbur sits down with guests Valerie Hike-Smith and Gwennie Echenagucia to discuss life post-Breast Cancer. From dating after a mastectomy, losing friends, to a new relationship with your body — they share their experiences with the Breast Cancer journey. Brought to you by: Hologic

It’s October, which means it’s Breast Cancer Awareness Month. So if you’re over 40, don’t forget to schedule your annual mammogram, especially if you missed it last year due to the pandemic. Ask your doctor about the Genius Exam — it’s clinically proven to detect more invasive breast cancers.* Visit https://www.findmygenius3d.com/ to find a Genius exam in your area.

About GOOD SUPPORT:
For Breast Cancer Awareness Month, ellentube and Hologic have teamed up to release a new mini-series, “Good Support,” hosted by Actress Angela Trimbur. For each of the 3 episodes, Angela sits down with a rotating panel of guests to discuss their experiences with Breast Cancer. From diagnosis to treatment, mastectomies, and lumpectomies, to life in remission, Angela and her guests have an open and honest conversation about the journey of Breast Cancer and how you can help support loved ones going through it, too.

Subscribe to The Ellen Show: https://youtube.com/theellenshow?sub_...

*Compared to 2D alone
[1] FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005.
[1] Results from Friedewald, SM, et al. “Breast cancer screening using tomosynthesis in combination with digital mammography.” JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia® Dimensions® on screening outcomes. Individual results may vary. The study found an average 41% increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1,000 screening exams were found in women receiving combined 2D FFDM and 3D™ mammograms acquired with the Hologic 3D Mammography™ System versus women receiving 2D FFDM mammograms only.
[1] Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.
[1] Smith, A. Improving Patient Comfort in Mammography. Hologic WP-00119 Rev 003 (2017).

#Ellen #TheEllenShow #EllenDeGeneres #BreastCancerAwareness